- QMRO Home
- Blizard Institute
- Centre for Neuroscience, Surgery and Trauma
- Glatiramer acetate as a clinically and cost-effective treatment of relapsing multiple sclerosis over 10 years of use within the National Health Service: Final results from the UK Risk Sharing Scheme.
Browse
Administrators only